Navigation Links
MedSolutions Joins Call for Increased Attention on Diagnostic Errors
Date:4/8/2009

JAMA commentary highlights startling lack of focus on costly problem

NASHVILLE, Tenn., April 8 /PRNewswire/ -- MedSolutions (www.medsolutions.com), a provider of medical cost management services that help health plans control diagnostic imaging costs while improving quality of care, today commended a recent Journal of the American Medical Association (JAMA) commentary that calls for the medical community to address the growing issue of diagnostic errors.

In their report ("Diagnostic Errors - The Next Frontier for Patient Safety" - JAMA, March 11, 2009), Johns Hopkins patient safety experts David Newman-Toker, M.D., Ph.D., and Peter Pronovost, M.D., Ph.D., assert greater public and scientific focus is needed to prevent diagnosis-related harm.

Often unrecognized or unreported, diagnostic errors receive little attention despite the fact that they cause up to 80,000 hospital deaths a year and result in twice as many tort claims as medication errors. In addition, roughly 5 percent of autopsies reveal diagnostic errors for which correct diagnosis and treatment could have averted death. No statistics exist for misdiagnosis-related deaths in outpatients.

"Despite the popular current focus on medical errors like prescription drug errors and hospital-acquired infections, diagnostic errors likely cause more harm. Diagnostic errors get very little attention from the medical community or the media," said Curt Thorne, chief executive officer of MedSolutions. "It is great that such a respected institution has highlighted this under-reported truth. Financial costs of misdiagnosis are obvious. Clearly, it wastes money to give the patient the wrong treatment, while at the same time failing to provide the right treatment earlier can cause disease to advance, making it more costly to control. It is about more than money, however. The human costs of misdiagnosis can be devastating. We must also consider the tremendous human toll a wrong diagnosis can take."

The Johns Hopkins experts advocate an industry-wide focus on larger system failures that can lead to misdiagnosis. They also point to tools such as screening checklists, computerized diagnostic decision-support systems, and the use of independent diagnostic experts to review radiology and imaging test results as practical, low-cost solutions.

MedSolutions' Premerus(SM) Diagnostic Accuracy program is the first and only solution that reduces diagnostic errors and lowers overall expense. Premerus provides patients and the doctors who treat them with expert interpretation of imaging studies from some of the nation's leading diagnosticians.

Research affirms that a physician's degree of specialization and volume of experience reading certain types of scans dramatically increase the probability of accurate diagnosis. For example, a recent study published in the Journal of the National Cancer Institute found that while some physicians failed to identify breast cancer 71 percent of the time, those who specialized in mammography had an error rate of only 3 percent.

"With today's rapidly advancing technology and the growing complexity of medical imaging, it's not realistic to expect general radiologists to read tests as accurately as specialists," said Gregg Allen, M.D., chief medical officer of MedSolutions. "A wrong diagnosis can lead to the wrong treatment that not only fails to help the patient, but also carries the risk of side effects that can be worse than the original problem. We created Premerus on the principle that expert interpretation yields greater diagnostic precision and improved outcomes."

In addition to improving diagnostic accuracy, Premerus is proven to reduce costs associated with misdiagnosis, such as unnecessary therapies, unwarranted tests and additional treatment required to reverse the effects of wrong therapies. An independently validated study conducted by the actuarial firm Thomson Reuters shows that healthcare payors utilizing Premerus can expect near-term savings of $4.45 per member, per month when utilized in a commercial insured population. Savings could range even higher in a Medicare Advantage population due to greater incidence of co-morbid conditions, including disease processes such as cancer. Accurate diagnosis of cancer in the early stages has been associated with higher survival rates, as well as with being more cost effective to treat.

"Increased focus in the medical community and common sense solutions such as those outlined in the JAMA commentary are needed to increase awareness of diagnostic errors and advance the science of how to identify and prevent them," said Thorne. "We applaud Dr. Newman-Toker and Dr. Pronovost of Johns Hopkins for their efforts to bring this often overlooked, yet vitally important, issue to the forefront."

About MedSolutions

Using independently validated savings methodologies, MedSolutions specializes in intelligent cost management of medical services for commercial, Medicare and Medicaid payors. The company maintains management contracts for nearly 25 million individuals nationwide. Using robust data, predictive intelligence technology and clinical expertise, the company's innovative solutions extend beyond radiology management to other areas of medical specialty, including cardiology, oncology, ultrasound, emergency room and Premerus(SM) diagnostic accuracy. MedSolutions has been twice recognized for its Call Center operations by the prestigious J.D. Power and Associates Award. Visit www.medsolutions.com.


'/>"/>
SOURCE MedSolutions
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cielo MedSolutions Announces Strong Revenue Growth in 2008
2. Richard Greco Joins Mediware Board
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
5. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
6. Nick Childs Joins Grey New York as Director of Content Development
7. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
8. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
9. NASN Joins Partnership to Fight Chronic Disease
10. AstraZeneca Joins Local Walking Movement
11. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: